NCT01450579View on ClinicalTrials.gov

A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Healthy
Interventions
BIOLOGICAL

ASP7373

Intermuscular administration

BIOLOGICAL

Placebo

Intramuscular administration

Trial Locations (1)

Unknown

Kyushu

All Listed Sponsors
lead

UMN Pharma Inc.

INDUSTRY

NCT01450579 - A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter